Journal profile · Biochemistry, Genetics and Molecular Biology-Cell Biology

Journal of Extracellular Vesicles

ISSN 2001-3078 · Taylor and Francis Ltd. · Sweden

Journal of Extracellular Vesicles: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 21.44; fully open access; APC about USD 4,850; median 213 days to acceptance (92 articles, last 24 months); acceptance rate 15% (journal website); 203 articles in 2025; indexed in SCIE and Scopus.

Impact factor21.44Latest value listed by LetPub
CAS zoneZone 1 · Medicine2025 upgraded edition, major category · Top journal · 2026 Xinrui edition Zone 1 · Medicine
Review time213 daysMedian, submission to acceptance · 92 articles, last 24 months · PubMed
APCUSD 4,850Fully open access
Acceptance15%From the journal's website (2025)
Articles per year2032025 · OpenAlex count

Scope

Aims, scope and focus

Journal of Extracellular Vesicles is published by Taylor and Francis Ltd. and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Extracellular vesicles in disease, MicroRNA in disease regulation and RNA Interference and Gene Delivery, together about 63.6% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)

The Journal of Extracellular Vesicles is dedicated to advancing the field of extracellular vesicles (EVs) including foundational biology, cutting-edge technologies and translational applications. We aim to shape the EV field and propel it forward for the benefit of science and society. Journal of Extracellular Vesicles is an official journal of the International Society for Extracellular Vesicles. Our editorial board aims to bring together leading experts from academia, industry, and regulatory bodies to foster scientific excellence, innovation, and reproducibility in EV research. We welcome contributions that deepen our understanding of EV biology and promote the practical application of this knowledge. We are particularly interested in submissions in the following areas: Molecular and Cellular Mechanisms of EV Biogenesis and Signaling (all organisms) EVs in Health and Development (all organisms) EVs in Disease Mechanisms and Pathology (all organisms) EVs in inter-organism interactions EV-related technologies, methods, and models (all organisms) (including single vesicles techniques) EVs as Biomarkers and Clinical Indicators (all organisms) Therapeutic Applications of EVs (including bioengineering and synthetic biology) (all organisms) Translational Medicine, Clinical Trials and Regulatory Science In silico studies and applications for EV Biology (including bioinformatics and AI) EV characterisation studies, including omics which elucidate EV biology. Emerging Topics and Interdisciplinary Frontiers, including controversial or paradigm-challenging findings Education, Collaboration and Communication Initiatives that advance the field and promote reproducibility. The journal accepts original research papers, review articles, short communications, technical reports, position papers, editorials, and letters to the Editor. Supplementary material in the form of large datasets, protocols, videos etc. is encouraged. The journal operates a single-blind peer review policy. All articles will be made freely and permanently available online through gold open access publication. Indexing Information: CAS: Chemical Abstracts Service (ACS) Directory of Open Access Journals (DOAJ) Embase (Elsevier) MEDLINE/PubMed (NLM) Open Access Journal Index – OAJ (NSLC & CEPIEC) Science Citation Index Expanded (Clarivate Analytics) SCOPUS (Elsevier) Journal of Extracellular Vesicles deposits all articles in PMC (PubMed Central)

From the journal's Aims & Scope

Research area (LetPub): Biochemistry, Genetics and Molecular Biology-Cell Biology

Editor-in-chief Jennifer JonesPublisher website

Editorial board by country: 5 in mainland China (about 6%); most named United States 24, Italy 8, Mainland China 5, Germany 5, United Kingdom 3 (77 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Extracellular vesicles in diseaseBiochemistry, Genetics and Molecular Biology44.1%
  2. MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology14.5%
  3. RNA Interference and Gene DeliveryBiochemistry, Genetics and Molecular Biology5.1%
  4. Cell Adhesion Molecules ResearchMedicine4.7%
  5. Nanoplatforms for cancer theranosticsEngineering3.3%
  6. Circular RNAs in diseasesBiochemistry, Genetics and Molecular Biology3.2%
  7. interferon and immune responsesImmunology and Microbiology2.4%
  8. Bacterial Infections and VaccinesImmunology and Microbiology2.3%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
LevelCategoryZone
MajorMedicineZone 1
MinorCell BiologyZone 2

Top journal: yesReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
LevelCategoryZone
MajorMedicineZone 1
MinorCell BiologyZone 1

Top journal: yesReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
LevelCategoryZone
MajorMedicineZone 1
MinorCell BiologyZone 2

Top journal: yesReview journal: no

Database indexing

SCIEScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

MEDLINEPMCEmbaseCASPublisher website

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
21.44LetPub ·
Impact factor (publisher)
21.7Publisher website ·
Impact factor (publisher) 2025
21.7Publisher website ·
CiteScore 2026-06
24.6LetPub ·
CiteScore (publisher)
24.6Publisher website ·
CiteScore (publisher) 2025
24.6Publisher website ·
SJR 2026-06
3.64LetPub ·
SNIP 2026-06
2.84LetPub ·
h-index
174OpenAlex ·
i10-index
911OpenAlex ·
2-year mean citedness
20.84OpenAlex ·
Self-citation rate
3.7%LetPub ·
Share of gold OA articles
100%LetPub ·

Volume

Articles per year
170LetPub ·
Articles per year (publisher) 2025
178Publisher website ·
Downloads per year (publisher) 2025
1,334,511Publisher website ·

Articles by year OpenAlex count · 1,385 in total · the current year is incomplete

YearArticlesOpen accessCitations
2026166166194
20252032032,083
20241651658,852
20231171174,722
20221291298,377
202113013012,635

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with PubMed · to

213 daysMedian, submission to acceptance · P25–P75 160 days – 253 days

Acceptance to online
—
Submission to online
—
Sample
92 articles with submission and acceptance dates (370 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
about 12 weeksLetPub ·
Acceptance rate (publisher)
15%Publisher website ·
Acceptance rate (publisher) 2025
15%Publisher website ·
Submission to first decision
11 daysPublisher website ·
Submission to first decision 2025
11 daysPublisher website ·
Submission to acceptance 2025
192 daysPublisher website ·
Acceptance to publication 2025
29 daysPublisher website ·
Submission to publication (journal-reported)
about 10 weeksDOAJ ·
Peer review
Single anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessDOAJ

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
DOAJUSD 4,850 / GBP 3,760 / EUR 4,370YesCC BY, CC BY-ND, CC BY-NC, CC BY-NC-ND
OpenAlexUSD 4,410 / EUR 3,970 / GBP 3,420——
LetPubUSD 4,200 / GBP 3,260 / EUR 3,780Yes—

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

What to prepare4 items from the author guidelines
Abstract
200 words
Keywords
≥ 3
Reference style
Author–date
First submission
Free format: the journal's layout is not required
Publisher website · model-extracted, each line checked against the text
Article types accepted8
  1. editorialsOriginal Research articles; Review articles; Short communications; ISEV Position Papers; Perspectives papers; Technical reports; Editorials; Letters-to-the-Edit…Length not stated
  2. isev position papersOriginal Research articles; Review articles; Short communications; ISEV Position Papers; Perspectives papers; Technical reports; Editorials; Letters-to-the-Edit…Length not stated
  3. letters-to-the-editorOriginal Research articles; Review articles; Short communications; ISEV Position Papers; Perspectives papers; Technical reports; Editorials; Letters-to-the-Edit…Length not stated
  4. original research articlesOriginal Research articles; Review articles; Short communications; ISEV Position Papers; Perspectives papers; Technical reports; Editorials; Letters-to-the-Edit…Length not stated
  5. perspectives papersOriginal Research articles; Review articles; Short communications; ISEV Position Papers; Perspectives papers; Technical reports; Editorials; Letters-to-the-Edit…Length not stated
  6. review articlesOriginal Research articles; Review articles; Short communications; ISEV Position Papers; Perspectives papers; Technical reports; Editorials; Letters-to-the-Edit…Length not stated
  7. short communicationsOriginal Research articles; Review articles; Short communications; ISEV Position Papers; Perspectives papers; Technical reports; Editorials; Letters-to-the-Edit…Length not stated
  8. technical reportsOriginal Research articles; Review articles; Short communications; ISEV Position Papers; Perspectives papers; Technical reports; Editorials; Letters-to-the-Edit…Length not stated
Publisher website
Policy excerpts from the journal's websiteConflicts of interest, Data availability, Publication ethics, License & copyright, Peer review, Preprints
Conflicts of interest Conflict of Interest

In the interests of candor and to help readers to detect potential bias, JEV now requires authors of original research papers to declare any competing interests in relation to papers accepted for publication. Please submit one statement on behalf of all authors. Competing interests are defined as those that, through their potential influences on behavior or content or from perception of such poten…

Source ↗Publisher website ·
Data availability Data Sharing

Data sharing expected in public repository Model summary

JEV expects that data supporting the results in the paper will be archived in an appropriate public repository. Authors are required to provide a data availability statement to describe the availability or the absence of shared data. When data have been shared, authors are required to include in their data availability statement a link to the repository they have used, and to cite the data they ha…

Source ↗Publisher website ·
Publication ethics Publication Ethics

COPE member Model summary

JEV is a member of the Committee on Publication Ethics (COPE). Wiley’s Publication Ethics Guidelines can be found here. Read Wiley’s Top 10 Publishing Ethics Tips for Authors here.

Source ↗Publisher website ·
License & copyright

CC-BY/CC-BY-ND/CC-BY-NC/CC-BY-NC-ND license Model summary

This journal uses the CC-BY/CC-BY-ND/CC-BY-NC/CC-BY-NC-ND Creative Commons License.

Source ↗Publisher website ·
Peer review Peer Review and Ethics

Single-blind peer review model Model summary

The acceptance criteria for all papers are the quality and originality of the research and its significance to Journal of Extracellular Vesicles readership and to the field of extracellular vesicles. This journal operates under a single-blind peer review model. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requiremen…

Source ↗Publisher website ·
Preprints Preprint Policy

Preprints on non-commercial servers considered Model summary

JEV will consider for review articles previously available as preprints on non-commercial servers such as ArXiv, bioRxiv, psyArXiv, SocArXiv, engrXiv, etc. Authors may also post the submitted version of their manuscript to non-commercial servers at any time. Authors are requested to update any pre-publication version with a link to the final published article.

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
Taylor and Francis Ltd.
Country or region
Sweden
Language
English
ISSN
2001-3078
Society / sponsor
International Society for Extracellular Vesicles
Latest issue on the website
Volume 15, Issue 9 (September 2026)
Official links

FAQ

Frequently asked questions about Journal of Extracellular Vesicles

What CAS zone is Journal of Extracellular Vesicles in?

In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Extracellular Vesicles is in Zone 1 of Medicine, and in Zone 2 of the minor category Cell Biology; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Journal of Extracellular Vesicles?

The latest impact factor listed by LetPub is 21.44; CiteScore 24.6, h-index 174.

How long does peer review take at Journal of Extracellular Vesicles?

Based on the dates recorded on 92 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 213 days (interquartile range 160–253 days); authors report an average review time of about 12 weeks; the journal's website gives an acceptance rate of 15% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

What are the manuscript requirements of Journal of Extracellular Vesicles?

According to the journal's author guidelines: Abstract: 200 words; Keywords: ≥ 3; Reference style: Author–date; First submission: Free format: the journal's layout is not required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.

Where are the editorial board members of Journal of Extracellular Vesicles based?

Of the 77 board members whose country the journal's board page names, 5 (about 6%) are in mainland China; the countries named most often are United States (24), Italy (8) and Mainland China (5). Counted from the institutions listed on the board page; for reference only.

Which databases index Journal of Extracellular Vesicles?

According to LetPub and DOAJ records, Journal of Extracellular Vesicles is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE, PMC, Embase and CAS; that list has not been checked against each database.

Is Journal of Extracellular Vesicles open access, and what is the APC?

Journal of Extracellular Vesicles is a fully open-access journal. APC about USD 4,850.

Sources and updates

The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .